Pieris Pharmaceuticals Total Current Liabilities 1970-1969 | PVLA

Pieris Pharmaceuticals total current liabilities from 1970 to 1969. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Pieris Pharmaceuticals Annual Total Current Liabilities
(Millions of US $)
Pieris Pharmaceuticals Quarterly Total Current Liabilities
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.016B $0.043B
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
Stock Name Country Market Cap PE Ratio
NPK (NPKI) United States $0.626B 27.85
Performant Healthcare (PHLT) United States $0.245B 0.00
FTAC Emerald Acquisition (FLDD) United States $0.158B 0.00
Swiftmerge Acquisition (ANNA) United States $0.042B 0.00
Insight Acquisition (AMOD) United States $0.023B 0.00
Hanryu Holdings (GITS) South Korea $0.017B 0.00
LQR House (YHC) United States $0.011B 0.00
ATIF Holdings (ZBAI) China $0.009B 0.00
Lion Electric (LEVGQ) Canada $0.000B 0.00